1
|
Global tuberculosis report 2016. World
Health Organization; Geneva: pp. 1–201. 2016
|
2
|
Waitt CJ and Squire SB: A systematic
review of risk factors for death in adults during and after
tuberculosis treatment. Int J Tuberc Lung Dis. 15:871–885. 2011.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Barry CE III, Boshoff HI, Dartois V, Dick
T, Ehrt S, Flynn J, Schnappinger D, Wilkinson RJ and Young D: The
spectrum of latent tuberculosis: Rethinking the biology and
intervention strategies. Nat Rev Microbiol. 7:845–855. 2009.
View Article : Google Scholar : PubMed/NCBI
|
4
|
van Altena R, Duggirala S, Gröschel MI and
van der Werf TS: Immunology in tuberculosis: Challenges in
monitoring of disease activity and identifying correlates of
protection. Curr Pharm Des. 17:2853–2862. 2011. View Article : Google Scholar : PubMed/NCBI
|
5
|
Zhang X, Liu F, Li Q, Jia H, Pan L, Xing
A, Xu S and Zhang Z: A proteomics approach to the identification of
plasma biomarkers for latent tuberculosis infection. Diagn
Microbiol Infect Dis. 79:432–437. 2014. View Article : Google Scholar : PubMed/NCBI
|
6
|
Serada S and Naka T: Screening for novel
serum biomarker for monitoring disease activity in rheumatoid
arthritis using iTRAQ technology-based quantitative proteomic
approach. Methods Mol Biol. 1142:99–110. 2014. View Article : Google Scholar : PubMed/NCBI
|
7
|
Li C, He X, Li H, Zhou Y, Zang N, Hu S,
Zheng Y and He M: Discovery and verification of serum differential
expression proteins for pulmonary tuberculosis. Tuberculosis
(Edinb). 95:547–554. 2015. View Article : Google Scholar : PubMed/NCBI
|
8
|
World Health Organization, . International
Union Against Tuberculosis and Lung Disease; Royal Netherlands
Tuberculosis Association: Revised international definitions in
tuberculosis control. Int J Tuberc Lung Dis. 5:213–215.
2001.PubMed/NCBI
|
9
|
Lichtenstein DA and Mezière GA: Relevance
of lung ultrasound in the diagnosis of acute respiratory failure:
The BLUE protocol. Chest. 134:117–125. 2008. View Article : Google Scholar : PubMed/NCBI
|
10
|
Mi H, Huang X, Muruganujan A, Tang H,
Mills C, Kang D and Thomas PD: PANTHER version 11: Expanded
annotation data from Gene Ontology and Reactome pathways, and data
analysis tool enhancements. Nucleic Acids Res. 45(D1): D183–D189.
2017. View Article : Google Scholar : PubMed/NCBI
|
11
|
da Huang W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nature Protoc. 4:44–57. 2009. View Article : Google Scholar
|
12
|
Satoh K, Maniwa T, Oda T and Matsumoto K:
Proteomic profiling for the identification of serum diagnostic
biomarkers for abdominal and thoracic aortic aneurysms. Proteome
Sci. 11:272013. View Article : Google Scholar : PubMed/NCBI
|
13
|
Zhang X, Zhang J, Li Q, Wu X, Wang T and
Wang Y: SELDI-TOF-MS in chronic obstructive pulmonary disease. Chin
Sci Bull. 58:pp634–640. 2013. View Article : Google Scholar
|
14
|
Hongmei Chen, Xiaoguang WU and Liping MA:
The clinical analysis of the hospitalized elderly patients died
from tuberculosis. Chin J Antituberculosis. 36:55–58. 2014.(In
Chinese).
|
15
|
Fournier T, Medjoubi-N N and Porquet D:
Alpha-1-acid glycoprotein. Biochim Biophys Acta. 1482:157–171.
2000. View Article : Google Scholar : PubMed/NCBI
|
16
|
Cordero Martìnez E, Gonzàlez MM, Aguilar
LD, Orozco EH and Pando Hernàndez R: Alpha-1-acid glycoprotein, its
local production and immunopathological participation in
experimental pulmonary tuberculosis. Tuberculosis (Edinb).
88:203–211. 2008. View Article : Google Scholar : PubMed/NCBI
|
17
|
Ichii O, Kimura J, Okamura T, Horino T,
Nakamura T, Sasaki H, Elewa YHA and Kon Y: IL-36α regulates
tubulointerstitial inflammation in the mouse kidney. Front Immunol.
8:13462017. View Article : Google Scholar : PubMed/NCBI
|
18
|
Ramadas RA, Ewart SL, Iwakura Y, Medoff BD
and LeVine AM: IL-36α exerts pro-inflammatory effects in the lungs
of mice. PLoS One. 7:e457842012. View Article : Google Scholar : PubMed/NCBI
|
19
|
Gopal R, Monin L, Torres D, Slight S,
Mehra S, McKenna KC, Junecko Fallert BA, Reinhart TA, Kolls J,
Báez-Saldaña R, et al: S100A8/A9 proteins mediate neutrophilic
inflammation and lung pathology during tuberculosis. Am J Respir
Crit Care Med. 188:1137–1146. 2013. View Article : Google Scholar : PubMed/NCBI
|
20
|
Kuipers MT, Vogl T, Aslami H, Jongsma G,
van den Berg E, Vlaar AP, Roelofs JJ, Juffermans NP, Schultz MJ,
van der Poll T, et al: High levels of S100A8/A9 proteins aggravate
ventilator-induced lung injury via TLR4 signaling. PLoS One.
8:e686942013. View Article : Google Scholar : PubMed/NCBI
|
21
|
Strålin P, Karlsson K, Johansson BO and
Marklund SL: The interstitium of the human arterial wall contains
very large amounts of extracellular superoxide dismutase.
Arterioscler Thromb Vasc Biol. 15:2032–2036. 1995. View Article : Google Scholar : PubMed/NCBI
|
22
|
Golubović S, Stanković I, Ristić L, Cosić
V, Dordević I and Radović M: Antioxidant enzymes and lipid
peroxidation products in patients with pulmonary tuberculosis. Med
Pregl. 63:450–453. 2010.(In Serbian). View Article : Google Scholar : PubMed/NCBI
|
23
|
Bouhafs RK and Jarstrand C:
Phagocyte-induced lipid peroxidation of lung surfactant. Pediatr
Pulmonol. 27:322–327. 1999. View Article : Google Scholar : PubMed/NCBI
|
24
|
Liao D, Fan Q and Bao L: The role of
superoxide dismutase in the survival of Mycobacterium tuberculosis
in macrophages. Jpn J Infect Dis. 66:480–488. 2013. View Article : Google Scholar : PubMed/NCBI
|
25
|
Gao F, Koenitzer JR, Tobolewski JM, Jiang
D, Liang J, Noble PW and Oury TD: Extracellular superoxide
dismutase inhibits inflammation by preventing oxidative
fragmentation of hyaluronan. J Biol Chem. 283:6058–6066. 2008.
View Article : Google Scholar : PubMed/NCBI
|